SUMOylation of DLX3 by SUMO1 promotes its transcriptional activity

Journal of Cellular Biochemistry

Volumn 112, Issue 2, 2011, Pages 445-452

  Duverger, Olivier ^a   Chen, Susie X ^a   Lee, Delia ^a   Li, Tianwei ^b   Chock, P Boon ^b   Morasso, Maria I ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

DLX3; DNA binding; nuclear localization; SUMO1; SUMOylation; transcriptional activity

Indexed keywords

ARGININE; LYSINE; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DLX3; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; GENETIC CONSERVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ALIGNMENT; SITE DIRECTED MUTAGENESIS; SUMOYLATION; TRANSCRIPTION INITIATION; WILD TYPE;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

VERTEBRATA;

EID: 79251623000     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22891     Document Type: Article

References (34)

1. Alkuraya FS, Saadi I, Lund JJ, Turbe-Doan A, Morton CC, Maas RL,. 2006. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 313: 1751.
2. Bhaskar V, Smith M, Courey AJ,. 2002. Conjugation of Smt3 to dorsal may potentiate the Drosophila immune response. Mol Cell Biol 22: 492-4504.
3. Bryan JT, Morasso MI,. 2000. The Dlx3 protein harbors basic residues required for nuclear localization, transcriptional activity and binding to Msx1. J Cell Sci 113: 4013-4023.
4. Depew MJ, Simpson CA, Morasso M, Rubenstein JL,. 2005. Reassessing the Dlx code: the genetic regulation of branchial arch skeletal pattern and development. J Anat 207: 501-561.
5. Desterro JM, Rodriguez MS, Hay RT,. 1998. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 2: 233-239.
6. Du JX, Bialkowska AB, McConnell BB, Yang VW,. 2008. SUMOylation regulates nuclear localization of Kruppel-like factor 5. J Biol Chem 283: 31991-32002.
7. Duverger O, Lee D, Hassan MQ, Chen SX, Jaisser F, Lian JB, Morasso MI,. 2008. Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome. J Biol Chem 283: 20198-20208.
8. Fuller-Pace FV, Jacobs AM, Nicol SM,. 2007. Modulation of transcriptional activity of the DEAD-box family of RNA helicases, p68 (Ddx5) and DP103 (Ddx20), by SUMO modification. Biochem Soc Trans 35: 1427-1429.
9. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD,. 2001. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J Biol Chem 276: 18513-18518.
10. Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G,. 1999. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18: 6462-6471.
11. Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, van Wijnen AJ, Stein GS, Stein JL, Lian JB,. 2004. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24: 9248-9261.
12. Hassan MQ, Tare RS, Lee SH, Mandeville M, Morasso MI, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB,. 2006. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem 281: 40515-40526.
13. Heun P,. 2007. SUMOrganization of the nucleus. Curr Opin Cell Biol 19: 350-355.
14. Huang YP, Wu G, Guo Z, Osada M, Fomenkov T, Park HL, Trink B, Sidransky D, Fomenkov A, Ratovitski EA,. 2004. Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype. Cell Cycle 3: 1587-1596.
15. Hwang J, Mehrani T, Millar SE, Morasso MI,. 2008. Dlx3 is a crucial regulator of hair follicle differentiation and cycling. Development 135: 3149-3159.
16. Jacobs AM, Nicol SM, Hislop RG, Jaffray EG, Hay RT, Fuller-Pace FV,. 2007. SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 26: 5866-5876.
17. Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC, Chock PB,. 2006. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 281: 36221-36227.
18. Morasso MI, Grinberg A, Robinson G, Sargent TD, Mahon KA,. 1999. Placental failure in mice lacking the homeobox gene Dlx3. Proc Natl Acad Sci U S A 96: 162-167.
19. Morasso MI, Radoja N,. 2005. Dlx genes, p63, and ectodermal dysplasias. Birth Defects Res C Embryo Today Rev 75: 163-171.
20. Morita Y, Kanei-Ishii C, Nomura T, Ishii S,. 2005. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol Biol Cell 16: 5433-5444.
21. Muller S, Berger M, Lehembre F, Seeler JS, Haupt Y, Dejean A,. 2000. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 275: 13321-13329.
22. Ouyang J, Valin A, Gill G,. 2009. Regulation of transcription factor activity by SUMO modification. Methods Mol Biol 497: 141-152.
23. Pichler A, Melchior F,. 2002. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 3: 381-387.
24. Poukka H, Karvonen U, Janne OA, Palvimo JJ,. 2000. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci U S A 97: 14145-14150.
25. Price JA, Bowden DW, Wright JT, Pettenati MJ, Hart TC,. 1998. Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. Hum Mol Genet 7: 563-569.
26. Robinson GW, Mahon KA,. 1994. Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for Distal-less homeobox genes in craniofacial development. Mech Dev 48: 199-215.
27. Seeler JS, Dejean A,. 2001. SUMO: of branched proteins and nuclear bodies. Oncogene 20: 7243-7249.
28. Tateishi Y, Ariyoshi M, Igarashi R, Hara H, Mizuguchi K, Seto A, Nakai A, Kokubo T, Tochio H, Shirakawa M,. 2009. Molecular basis for SUMOylation-dependent regulation of DNA binding activity of heat shock factor 2. J Biol Chem 284: 2435-2447.
29. Tsuruzoe S, Ishihara K, Uchimura Y, Watanabe S, Sekita Y, Aoto T, Saitoh H, Yuasa Y, Niwa H, Kawasuji M, Baba H, Nakao M,. 2006. Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun 351: 920-926.
30. Wang J, Li A, Wang Z, Feng X, Olson EN, Schwartz RJ,. 2007. Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol Cell Biol 27: 622-632.
31. Wang J, Zhang H, Iyer D, Feng XH, Schwartz RJ,. 2008. Regulation of cardiac specific nkx2.5 gene activity by small ubiquitin-like modifier. J Biol Chem 283: 23235-23243.
32. Wilson VG, Rangasamy D,. 2001. Intracellular targeting of proteins by sumoylation. Exp Cell Res 271: 57-65.
33. Yang SH, Jaffray E, Senthinathan B, Hay RT, Sharrocks AD,. 2003. SUMO and transcriptional repression: dynamic interactions between the MAP kinase and SUMO pathways. Cell Cycle 2: 528-530.
34. Zhang H, Hu G, Wang H, Sciavolino P, Iler N, Shen MM, Abate-Shen C,. 1997. Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. Mol Cell Biol 17: 2920-2932.